CDC researchers analyzed data on 2,952 adults admitted to 21 U.S. hospitals between Aug. 19 and Dec. 15, 2021. More than 1,800 adults in the analysis were immunocompromised.
Vaccines were 88 percent effective at preventing hospitalizations among immunocompromised people who had received a third dose, compared to 69 percent for those who only received two doses of an mRNA vaccine.
The study occurred when the delta variant was dominant in the U.S., but early evidence suggests a third mRNA vaccine dose strongly protects against severe illness from omicron, the CDC said.
Further research is needed to understand the level of protection third doses provide against omicron for different populations, including those who are immunocompromised.
View the full report here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
